dc.contributor.author | Mehata, A.K. | |
dc.contributor.author | Viswanadh, M.K. | |
dc.contributor.author | Priya, V. | |
dc.contributor.author | Vikas, V. | |
dc.contributor.author | Muthu, M.S. | |
dc.date.accessioned | 2020-10-26T05:18:31Z | |
dc.date.available | 2020-10-26T05:18:31Z | |
dc.date.issued | 2020-04 | |
dc.identifier.issn | 1743-5889 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/841 | |
dc.description.abstract | No abstract available | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Future Medicine Ltd. | en_US |
dc.relation.ispartofseries | Nanomedicine;Vol. 15 Issue 10 | |
dc.subject | dendritic cells | en_US |
dc.subject | drug targeting | en_US |
dc.subject | safety | en_US |
dc.subject | theranostics | en_US |
dc.subject | upconversion nanoparticles | en_US |
dc.title | Dendritic cell-targeted theranostic nanomedicine: Advanced cancer nanotechnology for diagnosis and therapy | en_US |
dc.type | Article | en_US |